Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Effect of cyclosporine in a murine model of experimental colitis (CROSBI ID 102080)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Banić, Marko ; Anić, Branimir ; Brkić, Tomislav ; Ljubičić, Neven ; Pleško, Sanja ; Dohoczky, C. ; Erceg, Damir. ; Petrovečki, Mladen ; Stipančić, Igor ; Rotkvić Ivo Effect of cyclosporine in a murine model of experimental colitis // Digestive diseases and sciences, 47 (2002), 6; 1362-1368. doi: 10.1023/A:1015339018181

Podaci o odgovornosti

Banić, Marko ; Anić, Branimir ; Brkić, Tomislav ; Ljubičić, Neven ; Pleško, Sanja ; Dohoczky, C. ; Erceg, Damir. ; Petrovečki, Mladen ; Stipančić, Igor ; Rotkvić Ivo

engleski

Effect of cyclosporine in a murine model of experimental colitis

The use of immunosuppressive therapy may be associated with significant toxicity. The aim of this study was to investigate the effect of cyclosporine A (CsA) in murine model of experimental colitis. Experimental colitis was induced in NMRI mice using an enema of 0.2% solution of dinitrofluorobenzene, combined with skin sensitization. After inducing colitis, experimental groups of animals were treated with CsA (1, 3, 5, 10, 25, 50 mg/kg/day) intraperitoneally (i.p.) or intracolonically (i.c.), and control groups were treated with phosphate-buffered saline intraperitoneally or intracolonically, respectively. Colonic inflammatory changes were assessed using a histopathologic score of 0-30, and pooled whole blood samples were processed with monoclonal antibodies for cyclosporine concentration. In addition, two groups of animals with experimental colitis were treated intraperitoneally or intracolonically with 3 mg/kg/day of CsA, and the colons were also taken for immunohistoche!mistry for CD25. CsA diminished the extent of colitis in groups treated with 3, 5, 10, or 25 mg/kg intraperitoneally or intracolonically, and in groups treated with 1 and 50 mg/kg intracolonically (P < 0.05). The effect of intracolonic application of CsA was not related to whole blood cyclosporine concentrations. In addition, the effect of CsA at 3 mg/kg, applied intraperitoneally or intracolonically was, in part, expressed in decreasing the numbers of CD25+ cells within colonic mucosa/submucosa (P < 0.05). In conclusions, the results of this study indicate the possibility of intracolonic application of cyclosporine in order to widen the therapeutic window for effective, but possibly toxic drug, such as cyclosporine.

effect of cyclosporine; inflammatory bowel disease; experimental colitis; inflammation; cyclosporine a

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

47 (6)

2002.

1362-1368

objavljeno

0163-2116

10.1023/A:1015339018181

Povezanost rada

Javno zdravstvo i zdravstvena zaštita, Kliničke medicinske znanosti

Poveznice
Indeksiranost